Summit Therapeutics
SMMT · NASDAQ
$16.09+$0.52 (+3.34%)TodayMarket closed ·
Prev close $15.57
Who owns SMMT
Largest institutional holders, from their latest 13F filings
The 10 largest institutions hold 90.0% of SMMT’s shares.
- Duggan (Robert William)71.9%
- Zanganeh (Mahkam)4.5%
- Baker Bros. Advisors LP4.1%
- Xia (Yu)4.0%
- Next 6 largest institutions5.4%
- All other shareholders10.0%
| Holder | Shares | % of shares |
|---|---|---|
| Duggan (Robert William) | 573.88M | 71.94% |
| Zanganeh (Mahkam) | 36.03M | 4.52% |
| Baker Bros. Advisors LP | 32.79M | 4.11% |
| Xia (Yu) | 32.06M | 4.02% |
| Fidelity Management & Research Company LLC | 10.04M | 1.26% |
| State Street Investment Management (US) | 9.54M | 1.20% |
| BlackRock Institutional Trust Company, N.A. | 7.57M | 0.95% |
| Vanguard Capital Management, LLC | 5.73M | 0.72% |
| UBS Financial Services, Inc. | 5.23M | 0.66% |
| Vanguard Portfolio Management, LLC | 5.04M | 0.63% |
Largest mutual fund holders
| Holder | Shares | % of shares |
|---|---|---|
| State Street SPDR S&P Biotech ETF | 7.85M | 0.98% |
| Vanguard Total Stock Market Index Fund | 3.73M | 0.47% |
| Vanguard Small-Cap Index Fund | 2.68M | 0.34% |
| Fidelity Growth Company Fund | 2.65M | 0.33% |
| T. Rowe Price Health Sciences Fund | 2.53M | 0.32% |
Insider trades
Form 4 filings by officers, directors and large holders
Over the last 6 months, insiders bought $103.62M (6 trades) of SMMT on the open market, with no sales.
| Insider | Type | Shares | Value |
|---|---|---|---|
| Anand Bhaskar | Award | 100.00K | — |
| Zanganeh Mahkam | Buy | 3.81M | $49.99M |
| DUGGAN ROBERT W | Buy | 3.81M | $49.99M |
| Soni Manmeet Singh | Buy | 25.00K | $360.75K |
| Soni Manmeet Singh | Buy | 25.00K | $361.50K |
| Zanganeh Mahkam | Buy | 100.00K | $1.46M |
| DUGGAN ROBERT W | Buy | 100.00K | $1.46M |
Short interest
Settled Sep 30, 2026
- Shares short
- 41.16M
- Days to cover
- 4.84
- % of shares outstanding
- 5.16%
- Average daily volume
- 8.50M
- Change since last report
- +0.2%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.